Moreover, Panther pathway analysis revealed that in both cancers, RCAN1 may be involved positive regulation of T-cell activation and angiogenesis as well as the integrin, EGF receptor, TGF-β, and cadherin signaling pathway while negatively regulating the ubiquitin–proteasome pathway and DNA replication. The gene discussed is CDH17; the disease is cancer.